Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea

Microvascular Research

Volumn 62, Issue 1, 2001, Pages 15-25

  Zimmermann, Ralf C ^a   Hartman, Tipton ^a   Bohlen, Peter ^b   Sauer, Mark V ^a   Kitajewski, Jan ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Angiogenesis; Anti VEGF R2 antibody; Corpus luteum; Ovary; Rodent; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; CHORIONIC GONADOTROPIN; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY; SERIC GONADOTROPIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ADOLESCENT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLIC INHIBITION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OVARY; OVARY FOLLICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPEROVULATION;

MAMMALIA; RODENTIA;

EID: 0034925109     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.2001.2312     Document Type: Article

References (18)

1. Mechanisms of angiogenesis and arteriogenesis
2. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
3. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization
4. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
5. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
6. The biology of vascular endothelial growth factor
7. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice
8. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor
9. Role of vascular endothelial growth factor in ovarian physiology and pathology
10. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis
11. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel
12. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele
13. Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary
14. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
15. Halting angiogenesis suppresses carcinoma cell invasion
16. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium
17. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
18. Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy